PT  - JOURNAL ARTICLE
AU  - H U Bryant
AU  - J W Holaday
AU  - E W Bernton
TI  - Cysteamine produces dose-related bidirectional immunomodulatory effects in mice.
DP  - 1989 May 01
TA  - Journal of Pharmacology and Experimental Therapeutics
PG  - 424--429
VI  - 249
IP  - 2
4099  - http://jpet.aspetjournals.org/content/249/2/424.short
4100  - http://jpet.aspetjournals.org/content/249/2/424.full
SO  - J Pharmacol Exp Ther1989 May 01; 249
AB  - The sulfhydryl reducing agent, cysteamine, is known to functionally inactive prolactin and other neurohormones that have been recently shown to play a role as immunomodulators. Cysteamine was administered to mice to evaluate its effects upon immune organ size and mitogen-induced lymphocyte proliferative responses in relation to corresponding effects on the immunomodulatory hormones, prolactin and corticosterone. The lowest dose of cysteamine, 12.5 mg/kg given once per day for 3 consecutive days, produced significant elevations of both concanavalin A-(Con A) and lipopolysaccharide-induced blastogenesis. Serum prolactin levels were also significantly elevated with 12.5 mg/kg cysteamine. By contrast, at 300 and 400 mg/kg, cysteamine significantly reduced Con A and lipopolysaccharide-induced proliferation. This suppression of mitogen-induced proliferative responses was accompanied by marked atrophy of the thymus. Levels of both prolactin and corticosterone in the serum were significantly reduced at 400 mg/kg cysteamine. A positive correlation was observed between serum prolactin levels and Con A-induced proliferation as well as between serum prolactin and corticosterone levels in cysteamine-treated mice. The immunomodulatory effects of cysteamine were not limited to correlative effects on neuroendocrine parameters. A similar pattern of effects was observed following in vitro administration of cysteamine. Low concentrations in vitro (0.1 mM) stimulated Con A-induced proliferation of normal mouse splenocytes, and higher concentrations in vitro (2.0 mM) suppressed proliferation. These studies indicate that, depending upon the dose, cysteamine has bidirectional effects on mitogen-induced proliferation of lymphocytes; these effects are correlated with cysteamine-related alterations in the neuroendocrine status of the animal but may also be observed with direct addition of the drug to stimulated lymphocytes in culture.